Management of lithium-associated hyperparathyroidism with cinacalcet hydrochloride

Br J Hosp Med (Lond). 2023 Jan 2;84(1):1-3. doi: 10.12968/hmed.2022.0330. Epub 2023 Jan 3.

Authors

Sarah Craus¹, Emma L Mifsud², Simon Mifsud¹, Sandro Vella¹

Affiliations

¹ Department of Diabetes and Endocrinology, Mater Dei Hospital, Msida, Malta.
² Department of Medicine, Mater Dei Hospital, Msida, Malta.

PMID: 36708345
DOI: 10.12968/hmed.2022.0330

No abstract available

MeSH terms

Calcium
Cinacalcet / therapeutic use
Humans
Hyperparathyroidism* / chemically induced
Hyperparathyroidism* / drug therapy
Hyperparathyroidism, Secondary*
Lithium
Parathyroid Hormone

Substances

Cinacalcet
Lithium
Calcium
Parathyroid Hormone